UK NICE · March 17, 2026

Patients to get new medicines up to six months sooner under new joint MHRA-NICE approval process

MHRA and NICE are launching a streamlined approval process to deliver new medicines to patients 3 to 6 months earlier.

Low obligation Framework Pharmaceuticals Market Access & Reimbursement UK PharmaceuticalsReimbursement

Patients in England are set to receive some new medicines 3 to 6 months earlier under a streamlined approval process being launched by the MHRA and NICE.

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.